日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bone remineralization of lytic lesions in multiple myeloma - The Arkansas experience

多发性骨髓瘤溶骨性病变的骨再矿化——阿肯色州的经验

Mohan, Meera; Kumar, Manoj; Samant, Rohan; Van Hemert, Rudy Jr; Tian, Erming; Desai, Shivang; van Rhee, Frits; Thanendrarajan, Sharmilan; Schinke, Carolina; Suva, Larry J; Sharma, Shobhit; Milad, Mohamed; Kendrick, Samantha; Zangari, Maurizio

Innate Biomineralization

先天性生物矿化

Tian, Erming; Watanabe, Fumiya; Martin, Betty; Zangari, Maurizio

An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome

多发性骨髓瘤中获得的高风险染色体不稳定性表型:1q跳跃综合征

Sawyer, Jeffrey R; Tian, Erming; Walker, Brian A; Wardell, Christopher; Lukacs, Janet L; Sammartino, Gael; Bailey, Clyde; Schinke, Carolina D; Thanendrarajan, Sharmilan; Davies, Faith E; Morgan, Gareth J; Barlogie, Bart; Zangari, Maurizio; van Rhee, Frits

The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma

17p缺失和TP53双等位基因失活的程度对多发性骨髓瘤的临床结果有显著影响。

Thanendrarajan, Sharmilan; Tian, Erming; Qu, Pingping; Mathur, Pankaj; Schinke, Carolina; van Rhee, Frits; Zangari, Maurizio; Rasche, Leo; Weinhold, Niels; Alapat, Daisy; Bellamy, William; Ashby, Cody; Mattox, Sandra; Epstein, Joshua; Yaccoby, Shmuel; Barlogie, Bart; Hoering, Antje; Bauer, Michael; Walker, Brian A; Davies, Faith E; Morgan, Gareth J

An Evaluation of Gene Set Analysis for Biomarker Discovery with Applications to Myeloma Research

基因集分析在生物标志物发现中的应用评价及其在骨髓瘤研究中的应用

Hanna, Eve; Rémuzat, Cécile; Auquier, Pascal; Toumi, Mondher; Qu, Pingping; Tian, Erming; Barlogie, Bart; Morgan, Gareth; Crowley, John

Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression.

非编码基因组序列中的等位基因突变构建了新的转录因子结合位点,从而促进基因过度表达

Tian Erming, Børset Magne, Sawyer Jeffrey R, Brede Gaute, Våtsveen Thea K, Hov Håkon, Waage Anders, Barlogie Bart, Shaughnessy John D Jr, Epstein Joshua, Sundan Anders

In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes

在多发性骨髓瘤中,14q32易位是非随机的染色体融合,导致相应融合基因的高表达水平。

Tian, Erming; Sawyer, Jeffrey R; Heuck, Christoph J; Zhang, Qing; van Rhee, Frits; Barlogie, Bart; Epstein, Joshua

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

sIL-6r 的水平与 SNP rs2228145 和 1q21 扩增的发生率呈协同增加,这定义了中危多发性骨髓瘤亚组

Stephens Owen W, Zhang Qing, Qu Pingping, Zhou Yiming, Chavan Shweta, Tian Erming, Williams David R, Epstein Joshua, Barlogie Bart, Shaughnessy John D Jr

Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon

多发性骨髓瘤基因扩增新机制的证据:1q12着丝粒周围异染色质介导1q12约23扩增子的断裂-融合-桥循环

Sawyer, Jeffrey R; Tian, Erming; Thomas, Edward; Koller, Mark; Stangeby, Colin; Sammartino, Gael; Goosen, Linda; Swanson, Charles; Binz, Regina L; Barlogie, Bart; Shaughnessy, John

OH-2, a hyperdiploid myeloma cell line without an IGH translocation, has a complex translocation juxtaposing MYC near MAFB and the IGK locus

OH-2是一种不具有IGH易位的超二倍体骨髓瘤细胞系,其具有复杂的易位,将MYC基因靠近MAFB基因和IGK基因座并置。

Våtsveen, Thea Kristin; Tian, Erming; Kresse, Stine H; Meza-Zepeda, Leonardo A; Gabrea, Ana; Glebov, Oleg; Dai, Hong Yan; Sundan, Anders; Kuehl, W Michael; Børset, Magne